CDKN1B and cancer: For example, in both ovarian [39] and prostate [76] cancer cell lines, 1,25(OH)2D3 treatment did not change p27 mRNA levels, but reduced mRNA expression of p45/Skp2 and Cks1 which are responsible for p27 protein ubiquitinylation and degradation [77].